.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,423,340

« Back to Dashboard

Summary for Patent: 6,423,340

Title: Method for the treatment of inflammatory bowel diseases
Abstract:Described herein are methods comprising the oral administration of budesonide for the treatment of ulcerative colitis and Crohn's colitis in its active phase. The methods can also be applied as relapse preventing therapy for Crohn's colitis in its chronic phase and Crohn's disease in the small intestine.
Inventor(s): Ulmius; Jan (Lund, SE)
Assignee: Aktiebolaget Draco (Sodertalje, SE)
Application Number:09/159,301
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 16th percentile
Forward Citations: 0th percentile

No matches for this query

Premature patent expiration for: 6,423,340

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
6,423,340 July 23, 2014

Foreign Priority and PCT Information for Patent: 6,423,340

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8903914Nov 15, 1990
PCT Information
PCT FiledNovember 15, 1990PCT Application Number:PCT/SE90/00738
PCT Publication Date:May 30, 1991PCT Publication Number: WO91/07172

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc